TAVIST-1 Drug Patent Profile
✉ Email this page to a colleague
When do Tavist-1 patents expire, and what generic alternatives are available?
Tavist-1 is a drug marketed by Haleon Us Holdings and Novartis and is included in two NDAs.
The generic ingredient in TAVIST-1 is clemastine fumarate. There are two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the clemastine fumarate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tavist-1
A generic version of TAVIST-1 was approved as clemastine fumarate by TEVA on January 31st, 1992.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TAVIST-1?
- What are the global sales for TAVIST-1?
- What is Average Wholesale Price for TAVIST-1?
Summary for TAVIST-1
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 86 |
| Clinical Trials: | 1 |
| Patent Applications: | 3,376 |
| DailyMed Link: | TAVIST-1 at DailyMed |
Recent Clinical Trials for TAVIST-1
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of California, San Francisco | Phase 2 |
| Moorfields Eye Hospital NHS Foundation Trust | Phase 2 |
US Patents and Regulatory Information for TAVIST-1
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Haleon Us Holdings | TAVIST-1 | clemastine fumarate | TABLET;ORAL | 020925-001 | Aug 21, 1992 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Novartis | TAVIST-1 | clemastine fumarate | TABLET;ORAL | 017661-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Novartis | TAVIST-1 | clemastine fumarate | TABLET;ORAL | 017661-003 | Aug 21, 1992 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
